M14 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The M14 cell line is a human melanoma cell line derived from a metastatic skin lesion of an adult patient with melanoma. This cell line is widely used in cancer research, particularly in the study of melanoma biology, tumor progression, and the evaluation of potential therapeutic agents. M14 cells exhibit characteristics typical of malignant melanoma, including the ability to form tumors in immunocompromised mice, making them a valuable tool for in vivo studies in addition to in vitro experiments. In terms of molecular features, M14 cells have been reported to carry mutations in genes that are frequently altered in melanoma, including the BRAF gene. Specifically, M14 cells harbor the BRAF V600E mutation, which leads to constitutive activation of the MAPK/ERK signaling pathway, promoting cell proliferation and survival. This makes M14 an important model for studying targeted therapies, such as BRAF inhibitors, that are designed to exploit this mutation. Additionally, M14 cells have been utilized in immunotherapy research due to their expression of various melanoma-associated antigens and susceptibility to immune system modulation. Researchers using the M14 cell line should note that these cells are not suitable for therapeutic applications and are intended solely for research purposes, particularly those focusing on melanoma pathophysiology, drug screening, and the development of new therapeutic strategies. The M14 cell line remains a key resource for advancing our understanding of melanoma and exploring new avenues for treatment. |
|---|---|
| Organism | Human |
| Tissue | Skin |
| Disease | Amelanotic melanoma |
| Metastatic site | Right buttock, hypodermis |
| Synonyms | M14-MEL, UCLA-SO-M14, UCLA SO M14, UCLA-SO-14, UCLASO-M14, Melanoma 14, M-14 |
Characteristics
| Age | 33 |
|---|---|
| Gender | Male |
| Ethnicity | European |
| Morphology | Fibroblast-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | M14 (Cytion catalog number 302163) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1395 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 302163-300325 | Certificate of Analysis | 18. Aug. 2025 | 302163 |